5,609 Shares in Cabot Co. (NYSE:CBT) Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new stake in Cabot Co. (NYSE:CBT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 5,609 shares of the specialty chemicals company's stock, valued at approximately $512,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CBT. Delta Financial Group Inc. acquired a new position in shares of Cabot during the 4th quarter worth about $274,000. Handelsbanken Fonder AB increased its position in Cabot by 22.4% during the fourth quarter. Handelsbanken Fonder AB now owns 10,909 shares of the specialty chemicals company's stock worth $996,000 after buying an additional 2,000 shares during the last quarter. Principal Financial Group Inc. raised its stake in Cabot by 1.0% in the fourth quarter. Principal Financial Group Inc. now owns 149,344 shares of the specialty chemicals company's stock valued at $13,637,000 after buying an additional 1,468 shares during the period. Monument Capital Management lifted its position in shares of Cabot by 1.7% in the fourth quarter. Monument Capital Management now owns 28,516 shares of the specialty chemicals company's stock valued at $2,604,000 after buying an additional 483 shares during the last quarter. Finally, Manchester Capital Management LLC increased its holdings in shares of Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after acquiring an additional 1,584 shares during the last quarter. 93.18% of the stock is owned by institutional investors.

Cabot Stock Performance

Shares of Cabot stock traded down $4.33 during trading on Monday, reaching $81.67. The company's stock had a trading volume of 505,058 shares, compared to its average volume of 421,809. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The business's 50-day moving average price is $88.21 and its 200-day moving average price is $100.60. Cabot Co. has a 52 week low of $81.30 and a 52 week high of $117.46. The firm has a market cap of $4.43 billion, a PE ratio of 10.85, a P/E/G ratio of 0.74 and a beta of 1.19.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities analysts forecast that Cabot Co. will post 7.57 earnings per share for the current year.

Cabot announced that its board has initiated a stock repurchase program on Tuesday, December 3rd that authorizes the company to buyback 10,000,000 outstanding shares. This buyback authorization authorizes the specialty chemicals company to repurchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company's board believes its stock is undervalued.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a yield of 2.11%. Cabot's dividend payout ratio (DPR) is presently 22.84%.

Analyst Upgrades and Downgrades

CBT has been the subject of a number of research analyst reports. JPMorgan Chase & Co. reduced their price objective on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Tuesday, February 18th. Finally, Mizuho cut their price objective on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Cabot has a consensus rating of "Hold" and a consensus price target of $97.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.